Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Gross Margin Over TimeContracting
Percentile Rank55
3Y CAGR-3.4%
5Y CAGR-5.3%
Year-over-Year Change
Gross profit as a percentage of revenue
3Y CAGR
-3.4%/yr
vs +8.1%/yr prior
5Y CAGR
-5.3%/yr
Consistent
Acceleration
-11.6pp
Decelerating
Percentile
P55
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 72.88% | -60.2% |
| 2024 | 182.99% | +450.1% |
| 2023 | 33.26% | -58.9% |
| 2022 | 80.98% | +11.9% |
| 2021 | 72.38% | -24.2% |
| 2020 | 95.52% | -11.9% |
| 2019 | 108.39% | +83.1% |
| 2018 | 59.19% | -39.4% |
| 2017 | 97.71% | +115.9% |
| 2016 | -614.57% | - |